# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001104659-25-100264
Filing Date
2025-10-17
Accepted
2025-10-17 08:08:41
Documents
38
Period of Report
2025-10-17
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | plx-20251017x8k.htm iXBRL | 8-K | 41955
2 | EX-99.1 | plx-20251017xex99d1.htm | EX-99.1 | 36967
3 | EX-99.2 | plx-20251017xex99d2.htm | EX-99.2 | 35906
4 | GRAPHIC | plx-20251017xex99d1g001.jpg | GRAPHIC | 128782
5 | GRAPHIC | plx-20251017xex99d1g002.jpg | GRAPHIC | 287742
6 | GRAPHIC | plx-20251017xex99d1g003.jpg | GRAPHIC | 195720
7 | GRAPHIC | plx-20251017xex99d1g004.jpg | GRAPHIC | 94666
8 | GRAPHIC | plx-20251017xex99d1g005.jpg | GRAPHIC | 156214
9 | GRAPHIC | plx-20251017xex99d1g006.jpg | GRAPHIC | 112262
10 | GRAPHIC | plx-20251017xex99d1g007.jpg | GRAPHIC | 103745
11 | GRAPHIC | plx-20251017xex99d1g008.jpg | GRAPHIC | 101857
12 | GRAPHIC | plx-20251017xex99d1g009.jpg | GRAPHIC | 103873
13 | GRAPHIC | plx-20251017xex99d1g010.jpg | GRAPHIC | 140901
14 | GRAPHIC | plx-20251017xex99d1g011.jpg | GRAPHIC | 114850
15 | GRAPHIC | plx-20251017xex99d1g012.jpg | GRAPHIC | 110907
16 | GRAPHIC | plx-20251017xex99d1g013.jpg | GRAPHIC | 108425
17 | GRAPHIC | plx-20251017xex99d1g014.jpg | GRAPHIC | 122514
18 | GRAPHIC | plx-20251017xex99d1g015.jpg | GRAPHIC | 172485
19 | GRAPHIC | plx-20251017xex99d1g016.jpg | GRAPHIC | 160078
20 | GRAPHIC | plx-20251017xex99d1g017.jpg | GRAPHIC | 146678
21 | GRAPHIC | plx-20251017xex99d1g018.jpg | GRAPHIC | 134746
22 | GRAPHIC | plx-20251017xex99d1g019.jpg | GRAPHIC | 147947
23 | GRAPHIC | plx-20251017xex99d1g020.jpg | GRAPHIC | 125686
24 | GRAPHIC | plx-20251017xex99d1g021.jpg | GRAPHIC | 99257
25 | GRAPHIC | plx-20251017xex99d1g022.jpg | GRAPHIC | 126455
26 | GRAPHIC | plx-20251017xex99d2001.jpg | GRAPHIC | 10659
27 | GRAPHIC | plx-20251017xex99d2002.jpg | GRAPHIC | 5450
| Complete submission text file | 0001104659-25-100264.txt |  | 4391512

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
28 | EX-101.SCH | plx-20251017.xsd | EX-101.SCH | 2895
29 | EX-101.LAB | plx-20251017_lab.xml | EX-101.LAB | 16017
30 | EX-101.PRE | plx-20251017_pre.xml | EX-101.PRE | 10762
40 | EXTRACTED XBRL INSTANCE DOCUMENT | plx-20251017x8k_htm.xml | XML | 4912

Mailing Address 2 UNIVERSITY PLAZA SUITE 100 HACKENSACK NJ 07601
Business Address 2 UNIVERSITY PLAZA SUITE 100 HACKENSACK NJ 07601 201-696-9345
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33357 | Film No.: 251399010
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)